University College London Hospitals NHS Foundation Trust

University College London Hospitals NHS Foundation Trust (UCLH), situated in the heart of London, is one of the largest NHS Trusts in the United Kingdom, providing first-class acute and specialist services in seven hospitals.

University College London Hospitals balances the provision of highly rated, specialist services with acute services to the local populations of Camden, Islington, Westminster, Barnet, Enfield and Haringey. The Trust has a turnover of £738 million and contracts with over 70 commissioning bodies. UCLH hospitals see over 740,000 out-patients and admit over 115,000 patients each year.

Specialisms
UCLH specialises in women’s health and the treatment of cancer, cardiac, infection, neurological, gastrointestinal and oral disease.

In 2010 the Trust was chosen to be one of eight hyper-acute stroke units (HASUs) in London. HASUs treat patients in the first, vital, 72 hours after a stroke. The UCLH Hyper Acute Stroke Unit (HASU) opened at full capacity in July 2010 and expects an annual caseload of 1,800 patients. The in-hospital mortality for patients treated through HASU has been exceptionally low at 6%, compared to the national average of 27%.

Research Excellence
The Trust is committed to pioneering clinical research. In December 2006, in partnership with University College London (UCL), UCLH became one of the country’s five comprehensive biomedical research centres. In addition to this, the Trust is a founder member of the academic health science centre, UCL Partners, which brings together five of Britain’s world renowned medical research centres and hospitals. UCLP continues to lead to ground-breaking advances in research for the benefit of patients by sharing best practice across the partnership and promoting links to other centres of excellence in clinical research.

In April 2012, UCLH opened the UCH Macmillan Cancer Centre – the most advanced facility of its kind in the UK.

At any one time around 1,300 leading edge research projects are on-going across the Trust’s hospital sites, including over 200 clinical trials of medicinal products. The Trust works with over 60 medical research charities and industry partners.

Performance Facts

  • In 2011 the Trust was named London NHS hospital Trust of the year by the Dr Foster Hospital Guide. This was the second time in just three years that UCLH has been named a Dr Foster Trust of the Year and the third time in a decade
  • UCLH operates the best performing A&E in London against the four hour waiting time target
  • UCLH’s Hospital Standardised Mortality Rate is 67, one of the lowest rates nationally
  • In 2011 UCLH received the best CQC inpatient survey results for a non-single specialty hospital in London. For ‘overall views and experience’ UCLH was in the top 20% of Trusts nationally for the second year running
  • The latest NHS staff survey shows that the people who work at the Trust would recommend UCLH as a place to receive treatment
  • 97% of UCLH patients would recommend the Trust to family and friends

Chief Executive: David Probert

David Probert

David Probert

Chief Executive

David Probert became chief executive of UCLH on 31 August 2021. Prior to this, David was chief executive of Moorfields Eye Hospital NHS Foundation Trust, being appointed to that role in April 2016. One of his key achievements was to lay the foundations for Oriel, a pioneering new eye-care research, education and treatment centre in partnership with University College London.

Before he joined Moorfields, David was director of strategic development at UCLH, where he led the planning and development of our two new hospitals – the Royal National ENT and Eastman Dental Hospitals and the Grafton Way Building for surgery and cancer. David has also held senior operational leadership roles at the Royal Marsden NHS Foundation Trust and Guy’s and St Thomas’s NHS Foundation Trust.

David continues to present on a number of academic and training courses based on clinical leadership and management development. He has contributed to a number of publications and journals with clinical and non-clinical colleagues and personal development is a key area of interest and was a Fellow at The Institute of Healthcare Improvement (IHI) in Boston, USA. He is also a trustee of a number of charities